Indo-National Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
NIPPOBATRY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo-National Limited (Nippo Batteries) reported its Q1 FY26 results on August 12, 2025. Standalone revenue from operations rose 6.97% year-on-year to Rs. 119.44 crore, driven by improved rural demand, online/institutional channels, and product innovation. Standalone profit after tax jumped about 60% to Rs. 1.62 crore (vs Rs. 1.01 crore), with EPS at Rs. 2.16 vs Rs. 1.35. EBITDA, however, fell roughly 5% to Rs. 3.34 crore as the company stepped up marketing spend, pushing margin down to 2.8% from 3.1%. The board also approved re-appointment of the Managing Director and Joint Managing Director for 5 years, appointment of a new non-executive director, alteration of Articles of Association, and noted shareholder approval of the Helios Strategic Systems amalgamation scheme. The company invested Rs. 3.54 crore in Medcuore Medical Solutions and Rs. 8.50 crore in CCPS of Axial Aero during the quarter.
Standalone PAT growth of ~60% YoY is a clear positive, signalling improving core battery business profitability, though margin compression from higher marketing spend is a watchpoint. The board-level continuity in leadership and the impending Helios amalgamation could reshape the consolidated earnings mix; meanwhile, the Rs. 42.26 crore CCI penalty remains a pending contingent liability.